BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 23072722)

  • 1. Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner.
    Jin L; Hanigan CL; Wu Y; Wang W; Park BH; Woster PM; Casero RA
    Biochem J; 2013 Jan; 449(2):459-68. PubMed ID: 23072722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophosphamide perturbs cytosine methylation in Jurkat-T cells through LSD1-mediated stabilization of DNMT1 protein.
    Zhang J; Yuan B; Zhang F; Xiong L; Wu J; Pradhan S; Wang Y
    Chem Res Toxicol; 2011 Nov; 24(11):2040-3. PubMed ID: 22007908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation.
    Wang J; Hevi S; Kurash JK; Lei H; Gay F; Bajko J; Su H; Sun W; Chang H; Xu G; Gaudet F; Li E; Chen T
    Nat Genet; 2009 Jan; 41(1):125-9. PubMed ID: 19098913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of LSD1 gene modulates histone methylation and acetylation and induces the apoptosis of JeKo-1 and MOLT-4 cells.
    Zou ZK; Huang YQ; Zou Y; Zheng XK; Ma XD
    Int J Mol Med; 2017 Aug; 40(2):319-328. PubMed ID: 28627608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer.
    Battaglia S; Karasik E; Gillard B; Williams J; Winchester T; Moser MT; Smiraglia DJ; Foster BA
    Clin Epigenetics; 2017; 9():82. PubMed ID: 28811844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNMT1 modulates gene expression without its catalytic activity partially through its interactions with histone-modifying enzymes.
    Clements EG; Mohammad HP; Leadem BR; Easwaran H; Cai Y; Van Neste L; Baylin SB
    Nucleic Acids Res; 2012 May; 40(10):4334-46. PubMed ID: 22278882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of downstream metastasis-associated target genes regulated by LSD1 in colon cancer cells.
    Chen J; Ding J; Wang Z; Zhu J; Wang X; Du J
    Oncotarget; 2017 Mar; 8(12):19609-19630. PubMed ID: 28121627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes.
    Huang Y; Stewart TM; Wu Y; Baylin SB; Marton LJ; Perkins B; Jones RJ; Woster PM; Casero RA
    Clin Cancer Res; 2009 Dec; 15(23):7217-28. PubMed ID: 19934284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The re-expression of the epigenetically silenced e-cadherin gene by a polyamine analogue lysine-specific demethylase-1 (LSD1) inhibitor in human acute myeloid leukemia cell lines.
    Murray-Stewart T; Woster PM; Casero RA
    Amino Acids; 2014 Mar; 46(3):585-94. PubMed ID: 23508577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interplay between the lysine demethylase KDM1A and DNA methyltransferases in cancer cells is cell cycle dependent.
    Brenner C; Luciani J; Bizet M; Ndlovu M; Josseaux E; Dedeurwaerder S; Calonne E; Putmans P; Cartron PF; Defrance M; Fuks F; Deplus R
    Oncotarget; 2016 Sep; 7(37):58939-58952. PubMed ID: 27449289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.
    Metzger E; Imhof A; Patel D; Kahl P; Hoffmeyer K; Friedrichs N; Müller JM; Greschik H; Kirfel J; Ji S; Kunowska N; Beisenherz-Huss C; Günther T; Buettner R; Schüle R
    Nature; 2010 Apr; 464(7289):792-6. PubMed ID: 20228790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
    Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
    Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.
    Feng Z; Yao Y; Zhou C; Chen F; Wu F; Wei L; Liu W; Dong S; Redell M; Mo Q; Song Y
    J Hematol Oncol; 2016 Mar; 9():24. PubMed ID: 26970896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of the DNA mismatch repair gene MLH1 induced by hypoxic stress in a pathway dependent on the histone demethylase LSD1.
    Lu Y; Wajapeyee N; Turker MS; Glazer PM
    Cell Rep; 2014 Jul; 8(2):501-13. PubMed ID: 25043185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant p53 binds to estrogen receptor negative promoter via DNMT1 and HDAC1 in MDA-MB-468 breast cancer cells.
    Arabsolghar R; Azimi T; Rasti M
    Mol Biol Rep; 2013 Mar; 40(3):2617-25. PubMed ID: 23242655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancer.
    Ding J; Zhang ZM; Xia Y; Liao GQ; Pan Y; Liu S; Zhang Y; Yan ZS
    Br J Cancer; 2013 Aug; 109(4):994-1003. PubMed ID: 23900215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide induces cell-cycle arrest and apoptosis of human multiple myeloma cells in vitro via altering expression of histone demethylase LSD1 and JMJD2B.
    Wen L; Chen Y; Zeng LL; Zhao F; Li R; Liu Y; Zhang C
    Acta Pharmacol Sin; 2012 Jan; 33(1):109-19. PubMed ID: 22120968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LSD1 knockdown reveals novel histone lysine methylation in human breast cancer MCF-7 cells.
    Jin Y; Huo B; Fu X; Cheng Z; Zhu J; Zhang Y; Hao T; Hu X
    Biomed Pharmacother; 2017 Aug; 92():896-904. PubMed ID: 28601046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal Structure of the LSD1/CoREST Histone Demethylase Bound to Its Nucleosome Substrate.
    Kim SA; Zhu J; Yennawar N; Eek P; Tan S
    Mol Cell; 2020 Jun; 78(5):903-914.e4. PubMed ID: 32396821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of tissue factor pathway inhibitor-2 (TFPI-2) expression by lysine-specific demethylase 1 and 2 (LSD1 and LSD2).
    Mino K; Nishimura S; Ninomiya S; Tujii H; Matsumori Y; Tsuchida M; Hosoi M; Koseki K; Wada S; Hasegawa M; Sasaki R; Murakami-Yamaguchi Y; Narita H; Suzuki T; Miyata N; Mizukami T
    Biosci Biotechnol Biochem; 2014; 78(6):1010-7. PubMed ID: 25036127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.